For: | Bhardwaj A, Singh A, Midha V, Sood A, Wander GS, Mohan B, Batta A. Cardiovascular implications of inflammatory bowel disease: An updated review. World J Cardiol 2023; 15(11): 553-570 [PMID: 38058397 DOI: 10.4330/wjc.v15.i11.553] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v15/i11/553.htm |
Number | Citing Articles |
1 |
Camila Sanchez Cruz, Anahi Rojas Huerta, Jesus Lima Barrientos, Cristina Rodriguez, Aarfa Devani, Vanessa Boosahda, Naga S Rasagna Mareddy, Gabriela Briceno Silva, Jose C Del Castillo Miranda, Kevin A Reyes Gochi, Mario D Reyes Gochi , Samantha Alvarez, Patricia E Ghattas Hasbun. Inflammatory Bowel Disease and Cardiovascular Disease: An Integrative Review With a Focus on the Gut Microbiome. Cureus 2024; doi: 10.7759/cureus.65136
|
2 |
Ondřej Kučerka, Martin Malý, Petra Mináriková, Jan M. Horáček. ATHEROSCLEROTIC CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Military Medical Science Letters 2024; doi: 10.31482/mmsl.2024.001
|
3 |
Gaurang H Suhagiya, Insha H Hamid, Demeke E Agago , Muhammad Arsalan, Mayankkumar D Dhakecha, Sandipkumar S Chaudhari, Calvin R Wei, Neelum Ali. Systematic Review and Meta-Analysis on the Impact of Atrial Fibrillation on Outcomes in Patients With Inflammatory Bowel Disease. Cureus 2024; doi: 10.7759/cureus.63795
|
4 |
Katarzyna Napiórkowska-Baran, Agata Doligalska, Magdalena Drozd, Marta Czarnowska, Dariusz Łaszczych, Marcin Dolina, Bartłomiej Szymczak, Oskar Schmidt, Zbigniew Bartuzi. Management of a Patient with Cardiovascular Disease Should Include Assessment of Primary and Secondary Immunodeficiencies: Part 2—Secondary Immunodeficiencies. Healthcare 2024; 12(19): 1977 doi: 10.3390/healthcare12191977
|